搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
生物通
24 天
靶向 IGF1R:开启小鼠继发性淋巴水肿治疗新希望
为解决继发性淋巴水肿病理机制及治疗难题,澳大利亚研究人员开展靶向 IGF1R 对小鼠继发性淋巴水肿影响的研究。结果发现 IGF1R 抑制剂 linsitinib 可限制其发展。该研究为淋巴水肿治疗提供新方向,值得科研人员一读。 淋巴水肿是一种让人十分困扰的疾病 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Pleads not guilty
Chiefs sign Tillery
Israeli attack in Gaza
Man wins $50M over burns
Kupp signs with Seahawks
Wins longest-ever Iditarod
Trump signs funding bill
To review F-35 jets purchase
Child abuse images sentence
Withdraws nomination
Influencer leaves Australia
Gold rises to new heights
Villanova fires head coach
Coffee creamer recall
Staff placed on leave
Cuba suffers power outage
Second protester arrested
Kellogg's envoy role reduced
Electrical fire halts show
Felony gun possession arrest
US expels SA ambassador
Deportation order blocked
Syed formally resentenced
RU, UKR launch attacks
Laceration hazard recall
US launches strikes in Yemen
Texas measles outbreak
North Macedonia deadly fire
ISIS leader killed in Iraq
Survives 95 days at sea
Severe weather outbreak
反馈